Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.

Journal of Virology
Melissa B PearceTerrence M Tumpey

Abstract

The influenza virus H1N1 pandemic of 1918 was one of the worst medical catastrophes in human history. Recent studies have demonstrated that the hemagglutinin (HA) protein of the 1918 virus and 2009 H1N1 pandemic virus [A(H1N1)pdm09], the latter now a component of the seasonal trivalent inactivated influenza vaccine (TIV), share cross-reactive antigenic determinants. In this study, we demonstrate that immunization with the 2010-2011 seasonal TIV induces neutralizing antibodies that cross-react with the reconstructed 1918 pandemic virus in ferrets. TIV-immunized ferrets subsequently challenged with the 1918 virus displayed significant reductions in fever, weight loss, and virus shedding compared to these parameters in nonimmune control ferrets. Seasonal TIV was also effective in protecting against the lung infection and severe lung pathology associated with 1918 virus infection. Our data demonstrate that prior immunization with contemporary TIV provides cross-protection against the 1918 virus in ferrets. These findings suggest that exposure to A(H1N1)pdm09 through immunization may provide protection against the reconstructed 1918 virus which, as a select agent, is considered to pose both biosafety and biosecurity threats.

References

Jan 1, 1988·Reviews of Infectious Diseases·H Smith, C Sweet
Dec 1, 1980·American Journal of Epidemiology·W H Barker, J P Mullooly
Jan 1, 1996·Epidemiologic Reviews·W P Glezen
Aug 9, 2001·The Journal of Infectious Diseases·M L HerlocherA S Monto
May 30, 2002·Virus Research·Christopher W Olsen
Aug 15, 2003·The Journal of General Virology·Ann H Reid, Jeffery K Taubenberger
Nov 12, 2003·Emerging Infectious Diseases·Ann H ReidJeffery K Taubenberger
Feb 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Terrence M TumpeyChristopher F Basler
Oct 8, 2005·Science·Terrence M TumpeyAdolfo García-Sastre
Jan 24, 2007·Vaccine·Marie Paule KienyKeiji Fukuda
May 2, 2008·Clinical and Vaccine Immunology : CVI·Bruce D ForrestWilliam C Gruber
Aug 22, 2009·Advances in Virus Research·Jessica A BelserTerrence M Tumpey
Sep 12, 2009·The New England Journal of Medicine·Kathy HancockJacqueline M Katz
Sep 22, 2009·Influenza and Other Respiratory Viruses·Christy Brockwell-StaatsRichard J Webby
Nov 6, 2009·JAMA : the Journal of the American Medical Association·Janice K LouieUNKNOWN California Pandemic (H1N1) Working Group
Jun 30, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ioanna SkountzouJoshy Jacob
Oct 5, 2010·Ageing Research Reviews·Pierre-Olivier LangRichard Aspinall
Oct 27, 2010·Nature Communications·Rafael A MedinaAdolfo García-Sastre
Sep 1, 2011·MBio·Peter Palese, Taia T Wang

❮ Previous
Next ❯

Citations

Oct 23, 2012·The Journal of Infectious Diseases·Matthew S MillerPeter Palese
Sep 13, 2012·MBio·Jeffery K TaubenbergerIan A Wilson
Apr 14, 2016·Infectious Diseases and Therapy·Ciaran D ScallanSean N Tucker
Jun 2, 2015·Travel Medicine and Infectious Disease·G Dennis Shanks
Apr 18, 2015·PloS One·Michelle C CrankUNKNOWN VRC 308 Study Team
Dec 25, 2019·Cold Spring Harbor Perspectives in Medicine·Jessica A BelserTaronna R Maines
Oct 5, 2019·Influenza and Other Respiratory Viruses·Julius WongStephen J Kent
Mar 2, 2019·Tropical Medicine and Infectious Disease·Joanna A Pulit-PenalozaTaronna R Maines

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.